Controllable dual-release of dexamethasone and bovine serum albumin from PLGA/β-tricalcium phosphate composite scaffolds

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 96 B, Issue 1, 2011, Pages 139-151

  Yang, Yanfang ^a   Tang, Gongwen ^a   Zhang, Hong ^a   Zhao, Yunhui ^a   Yuan, Xubo ^a   Wang, Min ^b   Yuan, Xiaoyan ^a  

^a TIANJIN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

bovine serum albumin; dexamethasone; dual release; microsphere; scaffold

Indexed keywords

BIODEGRADABLE SCAFFOLD; BOVINE SERUM ALBUMINS; COMPOSITE SCAFFOLDS; DEXAMETHASONES; DUAL-RELEASE; ENCAPSULATION EFFICIENCY; GLYCOLIDE; IN-VITRO; L-LACTIDE; MOLAR RATIO; PLGA MICROSPHERES; PROLONGED RELEASE; RELATIVE MOLECULAR MASS; RELEASE PROFILES; RELEASE RATE; TRI-CALCIUM PHOSPHATES;

BODY FLUIDS; DRUG DELIVERY; ENCAPSULATION; ETHYLENE; ETHYLENE GLYCOL; MICROSPHERES; MOLECULAR MASS; ORGANIC POLYMERS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYMER BLENDS; TISSUE ENGINEERING;

SCAFFOLDS;

BOVINE SERUM ALBUMIN; CALCIUM PHOSPHATE; DEXAMETHASONE; MACROGOL; MICROSPHERE; POLYGLACTIN; TISSUE SCAFFOLD;

ARTICLE; DRUG RELEASE; EMULSION; ENCAPSULATION; MOLECULAR WEIGHT; SPRAY DRYING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CATTLE; DEXAMETHASONE; DRUG IMPLANTS; HUMANS; MICROSPHERES; SERUM ALBUMIN, BOVINE; TISSUE SCAFFOLDS;

EID: 78650009799     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31752     Document Type: Article

References (29)

1. Laurencin CT, Khan Y, Kofron M, El-Amin S, Botchwey E, Yu XJ, Cooper JA,. Tissue engineering of bone and ligament-A 15-year perspective. Clin Orthop Relat Res 2006; 447: 221-236.
2. Lee SH, Shin H,. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Delivery Rev 2007; 59: 339-359.
3. Meyer U, Joos U, Wiesmann HP,. Biological and biophysical principles in extracorporal bone tissue engineering Part I. Int J Oral Max Surg 2004; 33: 325-332.
4. Puppi D, Chiellini F, Piras AM, Chiellini E,. Polymeric materials for bone and cartilage repair. Prog Polym Sci 2010; 35: 403-440.
5. Tessmar JK, Gopferich AM,. Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Delivery Rev 2007; 59: 274-291.
6. Yoon JJ, Kim JH, Park TG,. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials 2003; 24: 2323-2329.
7. Zhang Y, Zhang MQ,. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J Biomed Mater Res 2002; 62: 378-386.
8. Wei GB, Jin QM, Giannobile WV, Ma PX,. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release 2006; 112: 103-110.
9. Wang XQ, Weng E, Zhang XH, Meinel L, Vunjak-Novakovic G, Kaplan DL,. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 2009; 134: 81-90.
10. Sohier J, Vlugt TJH, Cabrol N, Van Blitterswijk C, de Groot K, Bezemer JM,. Dual release of proteins from porous polymeric scaffolds. J Control Release 2006; 111: 95-106.
11. Raiche AT, Puleo DA,. Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. J Biomed Mater Res A 2004; 69: 342-350.
12. Jaklenec A, Hinckfuss A, Bilgen B, Ciombor DM, Aaron R, Mathiowitz E,. Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffolds. Biomaterials 2008; 29: 1518-1525.
13. Riley CM, Fuegy PW, Firpo MA, Shu XZ, Prestwich GD, Peattie RA,. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials 2006; 27: 5935-5943.
14. Simmons CA, Alsberg E, Hsiong S,. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004; 35: 562-569.
15. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA,. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003; 88: 873-884.
16. Takita H, Tsuruga E, Ono I, Kuboki Y,. Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. Eur J Oral Sci 1997; 105: 588-592.
17. Raiche AT, Puleo DA,. In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials 2004; 25: 677-685.
18. Basmanav FB, Kose GT, Hasirci V,. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008; 29: 4195-4204.
19. Wang YJ, Shi XT, Ren L, Yao YC, Wang DA,. In vitro osteogenesis of synovium mesenchymal cells induced by controlled release of alendronate and dexamethasone from a sintered microspherical scaffold. J Biomater Sci Polym Ed 2010; 21: 1227-1238.
20. Kim H, Kim HW, Suh H,. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials 2003; 24: 4671-4679.
21. Yang YF, Zhao YH, Tang GW, Li H, Yuan XY, Fan YB,. In vitro degradation of porous poly(L -lactide-co-glycolide)/β-tricalcium phosphate (PLGA/β-TCP) scaffolds under dynamic and static conditions. Polym Degrad Stab 2008; 93: 1838-1845.
22. Wei GB, Pettway GJ, McCauley LK, Ma PX,. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials 2004; 25: 345-352.
23. Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P,. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: In vitro/in vivo studies. Eur J Pharm Biopharm 2004; 57: 207-212.
24. Lin XN, Zhou RM, Qiao Y, Jin FM, Zhai YL, Xing JF, Deng LD, Dong AJ,. Poly(ethyleneglycol)/poly(ethyl cyanoacrylate) amphiphilic triblock copolymer nanoparticles as delivery vehicles for dexamethasone. J Polym Sci Polym Chem 2008; 46: 7809-7815.
25. Corre PL, Guevello PL, Gajan V, Chevanne F, Verge RL,. Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres. Int J Pharm 1994; 107: 41-49.
26. Fu YJ, Shyu SS, Su FH, Yu PC,. Development of biodegradable co-poly(D, L -lactic/glycolic acid) microspheres for the controlled release of 5-FU by the spray drying method. Colloids Surf B 2002; 25: 269-279.
27. Zhao L, He CG, Gao YJ,. Study on influence of copolymer compositions of PLGA on properties of scaffolds. China Biotechnol 2008; 28: 22-28.
28. Hickey T, Kreutzer D, Burgess DJ, Moussy F,. Dexamethasone/PLGA microsphere for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002; 23: 1649-1656.
29. Blanco MD, Sastre RL, Teijón C, Olmo R, Teijón JM,. Degradation behaviour of microspheres prepared by spray-drying poly(D, L -lactide) and poly(D, L -lactide-co-glycolide) polymers. Int J Pharm 2006; 326: 139-147.